My current project dissects the role that the protein FAK plays on the induction of senescence observed in endothelial cells (ECs) after DNA damage therapy, and its role in lung cancer metastasis. We hypothesize that targeting EC-FAK in combination with DNA-damaging therapy can control cancer metastasis through senolytic effects.